Madrigal Pharmaceuticals, Inc.
MDGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001157601
In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Madrigal Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 266
- +41 vs. Q4 2023
- Shares held
- 21.1M
- +1.34M (+6.8%) vs. Q4 2023
- Total value
- $5.64B
- +$1.06B (+23.3%) vs. Q4 2023
- New holders
- 74
- 87 more added
- Sold out
- 33
- 78 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 414 | $12.7B |
| Q1 2026 | 380 | $12.4B |
| Q4 2025 | 387 | $13.7B |
| Q3 2025 | 352 | $10.7B |
| Q2 2025 | 305 | $7.13B |
| Q1 2025 | 321 | $7.85B |
| Q4 2024 | 283 | $7.08B |
| Q3 2024 | 257 | $4.77B |
| Q2 2024 | 257 | $6.41B |
| Q1 2024 | 266 | $5.64B |
| Q4 2023 | 226 | $4.57B |
| Q3 2023 | 206 | $2.54B |
| Q2 2023 | 208 | $3.43B |
| Q1 2023 | 223 | $3.36B |
| Q4 2022 | 189 | $3.86B |
| Q3 2022 | 135 | $763.2M |
| Q2 2022 | 138 | $857.7M |
| Q1 2022 | 140 | $1.20B |
| Q4 2021 | 144 | $1.01B |
| Q3 2021 | 133 | $876.5M |
| Q2 2021 | 151 | $1.09B |
| Q1 2021 | 137 | $1.43B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Madrigal Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 32,790 | $8.76M | 0.01% | +11,467+53.8% | Added |
| ArrowMark Colorado Holdings LLC | 34,219 | $9.14M | 0.10% | +34,219 | New |
| Skandinaviska Enskilda Banken AB (publ) | 35,112 | $9.38M | 0.05% | +29,840+566.0% | Added |
| Rockefeller Capital Management L.P. | 35,161 | $9.39M | 0.03% | +2,121+6.4% | Added |
| Rafferty Asset Management, LLC | 35,917 | $9.59M | 0.04% | −7,182−16.7% | Reduced |
| Rhenman & Partners Asset Management AB | 36,500 | $9.75M | 0.92% | +14,000+62.2% | Added |
| Rokos Capital Management LLP | 37,762 | $10.1M | 0.26% | +37,762 | New |
| Gilder Gagnon Howe & Co LLC | 39,083 | $10.4M | 0.13% | +39,083 | New |
| T. Rowe Price Investment Management, Inc. | 42,986 | $11.5M | 0.01% | +42,986 | New |
| Propel Bio Management, LLC | 43,032 | $11.5M | 6.69% | +13,000+43.3% | Added |
| Group One Trading, L.P. | 43,171 | $11.5M | 0.41% | −148,760−77.5% | Reduced |
| Deutsche Bank AG | 46,546 | $12.4M | 0.01% | −12,851−21.6% | Reduced |
| TD Asset Management Inc | 50,330 | $13.4M | 0.01% | +34,790+223.9% | Added |
| Driehaus Capital Management LLC | 50,709 | $13.5M | 0.13% | +50,709 | New |
| Sio Capital Management, LLC | 51,000 | $13.6M | 4.74% | +51,000 | New |
| Tri Locum Partners LP | 53,355 | $14.2M | 4.94% | +27,831+109.0% | Added |
| JPMorgan Chase & Co | 55,404 | $14.8M | 0.00% | −3,909−6.6% | Reduced |
| University of Wisconsin Foundation | 56,376 | $15.1M | 16.99% | −17,111−23.3% | Reduced |
| Bank of New York Mellon Corp | 57,883 | $15.5M | 0.00% | −4,295−6.9% | Reduced |
| Macquarie Group Ltd | 58,957 | $15.7M | 0.02% | +30,457+106.9% | Added |
| MPM Oncology Impact Management LP | 61,399 | $16.4M | 2.64% | +20,489+50.1% | Added |
| Fred Alger Management, LLC | 64,576 | $17.2M | 0.09% | +46,479+256.8% | Added |
| Nuveen Asset Management, LLC | 70,712 | $18.9M | 0.01% | +10,840+18.1% | Added |
| EcoR1 Capital, LLC | 75,000 | $20.0M | 0.51% | +75,000 | New |
| Emerald Mutual Fund Advisers Trust | 75,759 | $20.2M | 1.05% | +36,479+92.9% | Added |
| Invesco Ltd. | 80,192 | $21.4M | 0.00% | +71,530+825.8% | Added |
| Norges Bank | 89,950 | $24.0M | 0.00% | −55,639−38.2% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 92,253 | $24.5M | 0.05% | +30,745+50.0% | Added |
| Goldman Sachs Group Inc | 91,789 | $24.5M | 0.01% | +6,686+7.9% | Added |
| Ensign Peak Advisors, Inc | 92,218 | $24.6M | 0.04% | +30,806+50.2% | Added |
| Point72 Asset Management, L.P. | 93,571 | $25.0M | 0.07% | +93,571 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 93,597 | $25.0M | 0.11% | +39,490+73.0% | Added |
| Lord, Abbett & Co. LLC | 97,103 | $25.9M | 0.08% | +97,103 | New |
| American Century Companies Inc | 97,752 | $26.1M | 0.02% | +21,879+28.8% | Added |
| Emerald Advisers, LLC | 101,623 | $27.1M | 1.09% | +53,901+112.9% | Added |
| AlpInvest Partners B.V. | 105,744 | $28.2M | 11.03% | −105,744−50.0% | Reduced |
| Rheos Capital Works Inc. | 110,215 | $29.4M | 1.41% | +110,215 | New |
| Artal Group S.A. | 110,507 | $29.5M | 0.76% | +110,507 | New |
| Bank of America Corp | 113,114 | $30.2M | 0.00% | −1,790−1.6% | Reduced |
| Affinity Asset Advisors, LLC | 115,000 | $30.7M | 4.99% | +15,000+15.0% | Added |
| Charles Schwab Investment Management Inc | 122,692 | $32.8M | 0.01% | +2,480+2.1% | Added |
| Polar Capital Holdings Plc | 125,205 | $33.4M | 0.20% | +125,205 | New |
| UBS Group AG | 125,415 | $33.5M | 0.01% | +37,038+41.9% | Added |
| Tao Capital Management LP | 130,529 | $34.9M | 33.02% | 00.0% | Unchanged |
| Northern Trust Corp | 131,358 | $35.1M | 0.01% | −3,348−2.5% | Reduced |
| TCG Crossover Management, LLC | 149,283 | $39.9M | 3.15% | −30,634−17.0% | Reduced |
| Armistice Capital, LLC | 168,000 | $44.9M | 1.19% | +118,000+236.0% | Added |
| Pictet Asset Management Holding SA | 184,163 | $48.4M | 0.05% | +12,998+7.6% | Added |
| Bain Capital Life Sciences Investors, LLC | 196,995 | $52.6M | 4.23% | −127,624−39.3% | Reduced |
| Ra Capital Management, L.P. | 204,500 | $54.6M | 0.69% | 00.0% | Unchanged |
| Erste Asset Management GmbH | 250,625 | $66.6M | 0.91% | −74,375−22.9% | Reduced |
| Rock Springs Capital Management LP | 285,931 | $76.4M | 1.94% | +87,762+44.3% | Added |
| Morgan Stanley | 288,606 | $77.1M | 0.01% | +136,688+90.0% | Added |
| Geode Capital Management, LLC | 346,857 | $92.6M | 0.01% | +10,602+3.2% | Added |
| RTW Investments, LP | 397,047 | $106.0M | 1.57% | −418,144−51.3% | Reduced |
| Artisan Partners Limited Partnership | 401,709 | $107.3M | 0.16% | +105,229+35.5% | Added |
| Perceptive Advisors LLC | 429,953 | $114.8M | 2.02% | +278,802+184.5% | Added |
| State Street Corp | 624,938 | $166.9M | 0.01% | −75,801−10.8% | Reduced |
| FMR LLC | 713,914 | $190.6M | 0.01% | +88,749+14.2% | Added |
| Price T Rowe Associates Inc | 803,213 | $214.5M | 0.03% | +414,484+106.6% | Added |
| BlackRock Inc. | 1,210,391 | $323.2M | 0.01% | −2,171−0.2% | Reduced |
| Vanguard Group Inc | 1,668,806 | $445.6M | 0.01% | +94,064+6.0% | Added |
| Paulson & Co. Inc. | 1,775,000 | $474.0M | 32.74% | +669,259+60.5% | Added |
| Avoro Capital Advisors LLC | 1,944,444 | $519.2M | 6.06% | +55,556+2.9% | Added |
| Baker Bros. Advisors LP | 1,969,798 | $526.0M | 6.60% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 2,601,282 | $694.5M | 0.38% | −300,768−10.4% | Reduced |
| Summit Partners Public Asset Management, LLC | 0 | $0 | 0.00% | −82,287−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −69,406−100.0% | Sold out |
| L1 Capital Pty Ltd | 0 | $0 | 0.00% | −50,230−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −33,071−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −27,767−100.0% | Sold out |
| Rosalind Advisors, Inc. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −20,444−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −18,060−100.0% | Sold out |
| Osterweis Capital Management Inc | 0 | $0 | 0.00% | −15,147−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −12,458−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −9,900−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −7,763−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −5,227−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −4,503−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −4,063−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −3,716−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −2,350−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −2,293−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −2,200−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −1,551−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,474−100.0% | Sold out |
| Sierra Summit Advisors LLC | 0 | $0 | 0.00% | −1,434−100.0% | Sold out |
| MBB Public Markets I LLC | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,247−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −1,102−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −1,066−100.0% | Sold out |
| Marathon Trading Investment Management LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Edgestream Partners, L.P. | 0 | $0 | 0.00% | −987−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −953−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −857−100.0% | Sold out |
| Wit, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Able Wealth Management LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| AtonRa Partners | – | – | – | – | Not filed |